These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Galbraith WM; Hobson WC; Giclas PC; Schechter PJ; Agrawal S Antisense Res Dev; 1994; 4(3):201-6. PubMed ID: 7849490 [TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903 [TBL] [Abstract][Full Text] [Related]
10. Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study. Tonkinson JL; Guvakova M; Khaled Z; Lee J; Yakubov L; Marshall WS; Caruthers MH; Stein CA Antisense Res Dev; 1994; 4(4):269-78. PubMed ID: 7537561 [TBL] [Abstract][Full Text] [Related]
11. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides. Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469 [TBL] [Abstract][Full Text] [Related]
15. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Storey A; Oates D; Banks L; Crawford L; Crook T Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476 [TBL] [Abstract][Full Text] [Related]
16. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity. Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960 [TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides. Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161 [TBL] [Abstract][Full Text] [Related]
19. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys. Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591 [TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action. Henry SP; Giclas PC; Leeds J; Pangburn M; Auletta C; Levin AA; Kornbrust DJ J Pharmacol Exp Ther; 1997 May; 281(2):810-6. PubMed ID: 9152389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]